LONDON, Jan 21 (Reuters) - Iceland's Decode Genetics ehf returned as a private biotech company with new finance on Thursday after being acquired from its former parent by a consortium of investors.
The study is part of the PsychENCODE Consortium, which brings together multidisciplinary teams to generate large-scale gene expression and regulatory data from human brains across several major ...
SAN FRANCISCO, California, USA, 8 July 2025 – In a comprehensive Genomic Press Interview published in Brain Medicine, Dr. Michael C. Oldham shares his unconventional journey from advertising executive ...
An international team led by a University of Pittsburgh School of Medicine scientist has created a first-of-its-kind resource ...
Researchers have investigated how cationic polymers organize on a molecular level when transporting RNA drugs. LMU researchers have investigated how cationic polymers organize on a molecular level ...
UC San Diego researchers have settled a decades-long debate surrounding the role of the first Crohn's disease gene to be ...
CRISPR will get easier and easier to administer. What does that mean for the future of our species? In 2016, I attended a large meeting of journalists in Washington, DC. The keynote speaker was ...
Preliminary results from a small trial offer the clearest evidence yet that the brain disease’s progression can be slowed. A one-time gene therapy can markedly slow the progression of Huntington’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback